MARK CHANEY: Open Payments
NPI 1467055632 · EASTLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 15 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $412 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $85 |
| Novo Nordisk Inc | 2 | $47 |
| Medtronic, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $29 |
| BETA BIONICS, INC. | 2 | $24 |
| Sequel Med Tech, LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
Products named: TEPEZZA, MINIMED 780G, CRENESSITY, REPATHA, AYVAKIT, Wegovy, iLet Bionic Pancreas, Ozempic.
Industry payments across TX — which companies pay providers there.
